RRM2 and prostate cancer: While previous studies have highlighted the oncogenic roles of CDC20 and RRM2 in prostate cancer,33, 34, 35, 36 our work further demonstrates that DTL plays a comparable tumor-driving role in prostate cancer compared with CDC20 and RRM2.